vimarsana.com

Page 13 - உயிரி தொழில்நுட்பவியல் கண்டுபிடிப்பு ஆர்கநைஸேஶந் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Biotech Networks Launches at BIO 2021 Convention, Accelerating Life Science Growth with Hybrid Networking in California, Boston, and Worldwide

With Hundreds of Bio Industry Jobs Open and Company Expansions Underway, Companies Are Investing in

PORTLAND, Ore. (BUSINESS WIRE) #BioPro With large company expansions such as Micro Systems Engineering’s upcoming Lake Oswego-area advanced automated manufacturing expansion, Genentech’s Hillsboro Individualized Therapies facility, Bend’s Lonza expansion to build out new suites for the development and clinical ma.

Corporations should not have the power to undermine the global battle against Covid-19

Big pharma argues poor nations can t be trusted to make vaccines — Quartz

May 28, 2021 When it comes to the suspension of patents for Covid-19 vaccines, it’s big pharma against the world or most of it, anyway. Earlier this month, the US government expressed its support of a waiver to the international agreements governing intellectual property rights. The waiver, proposed in November 2020 by India and South Africa, would allow poor countries to produce Covid-19 vaccines without paying pharmaceutical companies for patent rights, at least until the pandemic is over. This would help increase the global supply of vaccines at a lower price, and make progress toward the goal of vaccinating the global population by the end of the year.

Big pharma argues poor nations can t be trusted to make vaccines

Big pharma argues poor nations can t be trusted to make vaccines Quartz 1 hr ago Annalisa Merelli © Provided by Quartz South African flag flies beside a flag bearing the logo of the vaccine manufacturing and storage company Biovac in Cape Town When it comes to the suspension of patents for Covid-19 vaccines, it’s big pharma against the world or most of it, anyway. Earlier this month, the US government expressed its support of a waiver to the international agreements governing intellectual property rights. The waiver, proposed in November 2020 by India and South Africa, would allow poor countries to produce Covid-19 vaccines without paying pharmaceutical companies for patent rights, at least until the pandemic is over. This would help increase the global supply of vaccines at a lower price, and make progress toward the goal of vaccinating the global population by the end of the year.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.